Joshua Maher, PhD

Research Scientist
JMI Laboratories

Poster(s):

• (2112) In vitro Activity of Cefiderocol and Comparator Agents Against Enterobacterales From United States Hospitals Stratified by Infection Type (2020-2022)
  Saturday, October 14, 2023

  12:15 PM – 1:30 PM US ET

• (2755) Activity of Aztreonam-avibactam and Carbapenem-resistant Enterobacterales (CRE) Isolates Collected in a Six-year Period (2017–2022)
  Saturday, October 14, 2023

  12:15 PM – 1:30 PM US ET

• (2761) Activity of Cefiderocol and Comparator Agents Against Achromobacter and Burkholderia Isolates, Collected During 2020-2022 as Part of SENTRY Antimicrobial Surveillance Program
  Saturday, October 14, 2023

  12:15 PM – 1:30 PM US ET

• (2762) Activity of Cefiderocol and Comparator Agents Against Difficult to Treat Resistance (DTR) Gram-negative Isolates, Collected During 2020-2022 as Part of SENTRY Antimicrobial Surveillance Program
  Saturday, October 14, 2023

  12:15 PM – 1:30 PM US ET

• (2790) Activity of Cefiderocol and Comparator Agents Against Pediatric Isolates of Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii-calcoaceticus species complex, and Stenotrophomonas maltophilia from the SENTRY Surveillance Program (2020-2022)
  Saturday, October 14, 2023

  12:15 PM – 1:30 PM US ET

• (2791) Antimicrobial Activity of Cefiderocol and Comparator Agents Against Isolates of Pseudomonas aeruginosa, Acinetobacter baumannii-calcoaceticus species complex, and Stenotrophomonas maltophilia by Infection Type from United States Hospitals in the SENTRY Antimicrobial Surveillance Program (2020-2022)
  Saturday, October 14, 2023

  12:15 PM – 1:30 PM US ET